Dr. David Isenberg is the Versus Arthritis Professor of Rheumatology at University College London (UCL). He graduated from St. Bartholomew’s Hospital, London in 1973 and trained in general medicine, rheumatology, neurology, psychiatry, and gastroenterology, becoming a Research Fellow at UCL/The Middlesex Hospital in 1979. He was awarded his MD in 1984, based on his studies of myositis. During a year of research at Tufts University, Boston, he became interested in autoantibody structure/function and origin. He was appointed Consultant Rheumatologist in 1984, Professor in 1991, and became the arc Diamond Jubilee Chair of Rheumatology at UCL in 1996. He is the past president of the British Society for Rheumatology (2004–2006) and he chaired the Society’s Biologics Register Committee for 5 years (2006–2011). He was the 2010 recipient of the Evelyn V. Hess Prize from the Lupus Foundation of America for his contribution to lupus research and treatment. His principal clinical interests are the development of disease activity and damage assessment tools in patients with lupus. His specialist interest is in the autoantibodies associated with systemic lupus erythematosus, Sjogren’s syndrome, myositis, and antiphospholipid antibody syndrome. In 2016, he became a Master of the American College of Rheumatology and in 2017 received the Rheumeritus award from the Portuguese Society for Rheumatology.
Dr. David Isenberg is the Versus Arthritis Professor of Rheumatology at University College London (UCL). He graduated from St. Bartholomew’s Hospital, London in 1973 and trained in general medicine, rheumatology, neurology, psychiatry, and gastroenterology, becoming a Research Fellow at UCL/The Middlesex Hospital in 1979. He was awarded his MD in 1984, based on his studies of myositis. During a year of research at Tufts University, Boston, he became interested in autoantibody structure/function and origin. He was appointed Consultant Rheumatologist in 1984, Professor in 1991, and became the arc Diamond Jubilee Chair of Rheumatology at UCL in 1996. He is the past president of the British Society for Rheumatology (2004–2006) and he chaired the Society’s Biologics Register Committee for 5 years (2006–2011). He was the 2010 recipient of the Evelyn V. Hess Prize from the Lupus Foundation of America for his contribution to lupus research and treatment. His principal clinical interests are the development of disease activity and damage assessment tools in patients with lupus. His specialist interest is in the autoantibodies associated with systemic lupus erythematosus, Sjogren’s syndrome, myositis, and antiphospholipid antibody syndrome. In 2016, he became a Master of the American College of Rheumatology and in 2017 received the Rheumeritus award from the Portuguese Society for Rheumatology.